Watch this video with Professor Gian Maria Rossolini on ATLAS : Antimicrobial Testing Leadership and Surveillance. Professor Rossolini covers the practical aspects of using the online ATLAS platform. A new, comprehensive, fully-searchable database available worldwide to support antibiotic resistance surveillance.
AMS Part III | How is the clinical & economic impact of an AMS program measured?
Mark Gilchrist, MPharm, MSc, IPres, FFRPS, Consultant Pharmacist, Infectious Diseases, UK presents on the topic of Antimicrobial Stewardship. How is the Clinical and Economic impact of an AMS program measured?
A pathogen, commonly known as a germ - is a living particle that causes disease or illness, most often by disrupting the normal functioning of the human body. But there's not just one kind. There are viruses, bacteria, fungi, prions and more. Download your Field Guide to Germs to learn more.
AMS Part II | How are AMS Programs implemented & What are the main goals?
Mark Gilchrist, MPharm, MSc, IPres, FFRPS, Consultant Pharmacist, Infectious Diseases, UK presents on the topic of Antimicrobial Stewardship. How are AMS programs implemented and what are the main goals?
When you hear the word fungus, you may think of mushrooms growing on a wet tree trunk, mould on old bread, or mildew at the back of the refrigerator. These are perhaps the most well-known forms of fungi(more than one fungus), but did you know that there are up to 1.5 million species of fungi, approximately 300 of which can cause illness in people?
Even though they’re rare, outbreaks of bacterial meningitis often make the news, which can lead to people having questions about the disease, including what it is, how it is treated and spread, and how it can be prevented. Read this article to learn some basic facts about bacterial meningitis.
A Superbug Problem | When routine surgeries turn dangerous
S. aureus is a common bacterium found on the skin and in the nose that is usually harmless. This all changes if it enters the body through cuts and grazes. To compound this in recent years, potentially life-threatening, antibiotic-resistant strains have emerged known as methicillin-resistant Staphylococcus aureus (MRSA).
Tackling sexually transmitted infections in Ireland
Sexually Transmitted Infections (STIs) are a problem, with the Health and Safety Executive (HSE) calling the current situation a ‘serious public health concern’1. The number of STI notifications in Ireland has risen in recent years2, going from 3,361 in 1995 to 12,753 in 2013 – an increase of 279%2.
In this short video, Dr Matthew Dryden, MD, FRCPath, Consultant, Department of Microbiology and Infection from Hampshire Hospitals speaks about how we can collectively combat the spread of Antimicrobial Resistance.
In this short video, Dr Matthew Dryden, MD, FRCPath, Consultant, Department of Microbiology and Infection from Hampshire Hospitals speaks about Antimicrobial Resistance and the steps we can take to protect our future.